About Us
Antelope Surgical Solutions, Inc. is a pre-revenue, clinical-stage radiopharmaceutical company based in NYC, focused on the research and development of novel small molecule drugs for radioligand-targeted therapy, PET imaging, and fluorescence-guided surgery in the treatment of various cancers.
Amy Wu, M.D.
Founder & CEO
Richard Ting, PhD
Chief Quality & Science Officer
Wayne Chou, PHD
Strategic Operations
Jeff Janotak, BS
Clinical Operations
Wave Chan, CPA
Controller
Wayne Chou, PHD
Strategic Operations
Chemistry, BSc, PhD
Assistant Professor (Research) in Chemistry
Experience running, building out wet labs, and grand submissions
Jeff Janotka, BS
Clinical Operations
Over 30 Years in clinical drug development.
Biotech and CRO with primary focus on oncology in the last 10-15 years.
Wave Chan, CPA
Controller
Over 25 years in finance, capital markets and strategy, and accounting
Leadership Team
Amy Wu, MD
Founder and CEO
Dr. Amy Wu is a board-certified, fellowship-trained otolaryngologist-head and neck surgeon and the Founder and CEO of Antelope Surgical Solutions, Inc., based in New York, NY. She specializes in voice, airway, and swallowing disorders and has an extensive background in research and innovation.
Dr. Wu earned her undergraduate degree in physics from the University of Pennsylvania and completed her medical degree at Stanford University. She pursued surgical residency at University of California- San Diego Medical Center and a fellowship at Mount Sinai West, honing her expertise in complex surgical procedures.
Throughout her career, Dr. Wu has been deeply committed to advancing medical science. She has published groundbreaking research alongside Nobel laureate Dr. Roger Tsien and actively collaborates with scientists to develop cutting-edge diagnostic and therapeutic agents. Under her leadership, Antelope Surgical Solutions has achieved significant milestones, including FDA commercial IND approval for its radioligand fluorescent technology, which aims to transform cancer diagnostics and treatment.
For more about Dr. Wu’s contributions to science and medicine, or to explore her publications, follow the links below.
Richard Ting, PhD,
Chief Quality and Science Officer
Dr. Richard Ting is a distinguished scientist who earned his undergraduate and graduate degrees from the University of British Columbia in Vancouver, Canada, where he also trained at the TRIUMF particle accelerator center. He completed postdoctoral studies under Nobel laureate Dr. Roger Tsien at the University of California, San Diego, where he began his collaboration with Dr. Amy Wu. Dr. Ting later led a successful academic chemistry lab in NYC and has published extensively with global collaborators. His expertise includes radiochemistry, fluorescent chemistry, GMP manufacturing, artificial intelligence, optics, and computer programming.